as a screening tool. It is less invasive, can be performed rapidly, and has a lower stroke risk than DSA. 6, 13 On the other hand, CTA exposes patients to additional radiation, as well as risks including contrast-induced nephropathy, allergic reactions, and even death. 4 Therefore, it is important to optimize the screening yield of CTA in isolated ICH. In addition, in the current setting of rationalization of health care costs, improving the yield and cost effectiveness of this diagnostic tool could decrease unnecessary expenses in patients with ICH, without compromising their health outcomes.
In the current study, we attempted to identify patients who do not benefit from CTA as part of an initial screening and quantify risk factors that could be used to increase the yield of CTA in the detection of vascular sources in patients with nontraumatic, nonsubarachnoid ICH.
Methods

Study Population
Radiological, diagnosis-related group, and operative procedure codes were used to identify patients admitted to Dartmouth-Hitchcock Medical Center between January 1, 2000, and September 1, 2008 , with the diagnosis of ICH. Exclusion criteria included patients with SAH, antecedent history of trauma, hemorrhagic conversion of infarct, or hemorrhage in the setting of a known brain tumor. The patients were selected by 2 independent investigators, and in case of disagreement, a third investigator was used.
Outcome Variables
For those meeting inclusion criteria, medical records were reviewed and the following parameters were collected: age, sex, location of hemorrhage, presence of the following conditions (hypertension, hypercholesterolemia, diabetes mellitus, atrial fibrillation, coronary artery disease, cerebrovascular disease), smoking history, and impaired coagulation. Patients were considered hypertensive if they had a history of hypertension on medical records or were taking antihypertensive medications at the time of presentation. Patients were classified as having impaired coagulation at presentation if they were receiving daily aspirin or antiplatelet agents, had a platelet count of less than 50,000 cells per cubic millimeter of blood, were receiving anticoagulation therapy using warfarin and had an international normalized ration greater than 2.0, or were receiving anticoagulation therapy using heparin and had an activated partial thromboplastin time of more than 80 seconds. Positive CTA was defined as a study in which an underlying vascular origin for the ICH was identified. These results were correlated with the results of conventional angiography, MRI, and pathology when available.
Imaging Specifications
Computed tomography and CTA were performed on 16-or 64-section helical CT scanners (Lightspeed or Lightspeed VCT, GE Healthcare). Noncontrast head CT was performed using axial acquisition with image sets produced at 5 mm and 1.5 mm. Computed tomography angiography was performed with helical acquisition of 0.625-mm slice thickness and spacing, at 120 kV, and a 20-cm FOV. During the intravenous injection of 65-110 ml of nonionic contrast material at 4-5 ml/sec, images were acquired from the foramen magnum to the cranial vertex. Scan delay was determined using a timing bolus. Image processing consisted of standard axial, coronal, and sagittal multiplanar volume-reformatted images and 3D volume-rendered reconstructions using an Advantage Workstation with Volume Viewer software (GE Healthcare). Physicians interpreting the 3D images could manipulate them.
Statistical Analysis
Chi-square tests were used to investigate the association of categorical baseline variables of interest with CTA. Logistic regression was used to investigate the combined effects of baseline variables of interest. Model selection was performed using the stepwise method as implemented in SAS, with a significance level of p = 0.10 for variable entry and p = 0.05 for variable retention.
Results
Demographics
From January 1, 2000, to September 1, 2008 , 1376 patients at our institution underwent head CT that demonstrated ICH. Of those patients, 514 underwent further investigation using CTA. Two hundred fifty-seven patients were excluded from the analysis based on the predefined exclusion criteria: SAH (219 patients), antecedent history of trauma (23 patients), hemorrhagic conversion of an infarct (5 patients), or hemorrhage in the setting of a known brain tumor (10 patients). Two hundred fifty-seven patients remained for analysis, with a mean age of 66.1 years (range 9-93 years); 51% of the patients were men.
Negative CTA for Source of Hemorrhage
Two hundred twenty-three patients had a negative CT angiogram in the initial evaluation of the cause of ICH (Table 1). These patients had a mean age of 67.9 years (range 30-93 years) and 52% were men. Sixty-eight patients had basal ganglia, thalamic, or brainstem hemorrhages, 121 had lobar hemorrhages, and 25 had a cerebellar hemorrhage. Fifty-two of the patients had impaired coagulation. Five patients had hemorrhages in newly diagnosed brain tumors. Sixteen of the patients with a negative vascular source of hemorrhage had an incidental aneurysm discovered on their CTA that was not a source of the ICH. One patient had negative CTA, but was investigated further using DSA given his young age (less than 45 years old), and was found to have an AVM. Two of the CTA-negative patients (younger than 45 years old) had negative DSA and were found to have a cavernous malformation on MRI.
Positive CTA
Thirty-four patients had a positive CTA finding (Table 1). These patients had a mean age of 54.1 years (range 9-82 years) and 44% were men. Of the 34 patients with a positive CTA, 9 had parietal AVMs ( Fig. 1 ), 3 had frontal AVMs, 3 had cerebellar AVMs, 2 had temporal AVMs, 2 had brainstem AVMs, 1 had a basal ganglia AVM, 3 had dural arteriovenous fistulas, 2 had Moyamoya disease ( Fig. 2) , 5 had ruptured middle cerebral artery aneurysms, 2 had ruptured anterior communicating artery aneurysms, 1 had a ruptured posterior communicating artery aneurysm, and 1 had a superior sagittal sinus thrombosis. With the exception of those patients with aneurysms and sinus thrombosis, all patients underwent DSA before eventual operative intervention.
Baseline Characteristics
Patients with a negative CTA were older (p < 0.001) and had a significantly higher incidence of hypertension (p < 0.001), hypercholesterolemia (p < 0.001), heart disease (p < 0.001), smoking history (p < 0.001), and impaired coagulation (p = 0.036; Table 1 ). Isolated temporal lobe hemorrhage was significantly higher in patients with a positive CT angiogram (p < 0.001).
Multivariate Logistic Regression Analysis
Patients who were found to have a structural cause of hemorrhage on CTA had the following significant characteristics: younger than 65 years old (OR = 16.36, p = * All values given as number of patients (%) unless otherwise indicated. Table 2 ). Patients who were older than 65 and had hypertension were never found to have a positive CT angiogram. In contrast, patients younger than 45 years of age who were without hypertension, smoking history, or impaired coagulation were all found to have a positive CTA, except from 1 patient with an unremarkable CT angiogram but who was found to have an AVM on subsequent DSA, and 2 patients who were found to have cavernous malformations on subsequent MR images.
Discussion
Spontaneous ICH affects a significant portion of the US population every year. 3, 18 It is associated with a 35%-52% 30-day mortality rate, 3, 10 with only 38% of patients surviving the first year.
18 When a vascular lesion is the cause of the ICH, its identification is imperative to prevent further morbidity and death from recurrent hemorrhage. 1, 3, 9, 17, 18 Prior reports have recommended that all patients with ICH undergo a further workup for vascular pathology, with at least 1 screening study. 8, 15 However, given the low likelihood of discovering vascular lesions in ICH, this strategy is both cost-intensive and exposes patients to risks of radiation, contrast-induced renal injury, and death.
To improve the yield of angiography in the workup of acute spontaneous ICH, several investigators have attempted to identify high-risk patient populations that would benefit from its use. 7, 11, 14, 16 and temporal or frontal lobe location 7, 14 have all been identified as features that increase the chance of finding a vascular source through DSA. In addition, criteria have been developed to stratify ICH patients as low or high risk for a vascular lesion based on findings on noncontrast head CT. 5 However, Halpin et al. 8 found vascular causes of ICH using conventional angiography in 24% of patients deemed unlikely to have positive findings based on the head CT criteria. Specifically, 13% of hypertensive patients, 18% of patients with posterior fossa hemorrhage, and 31% of patients with basal ganglia hemorrhage were found to have a vascular cause for their ICH. In addition, Matsumoto et al. 15 found coexisting aneurysms in 21% of women and 9% of men presenting with hypertensive ICH.
Both of these groups have advocated the universal use of DSA as an initial screening tool in all patients presenting with spontaneous ICH.
At many institutions, CTA has largely replaced DSA as the first diagnostic test in the workup of spontaneous ICH, 5 given its efficiency and lower complication risk. In an attempt to investigate the diagnostic accuracy of CTA, Delgado Almandoz et al. 5 performed a retrospective analysis of their data on ICH, with the use of CTA as the initial screening tool. Their results confirmed the high sensitivity and specificity of CTA in identifying vascular lesions, and they also demonstrated that younger age, lobar or infratentorial hemorrhage, female sex, and no history of hypertension or impaired coagulation are more prevalent in patients with positive CTA. They then devised a secondary ICH score combining these parameters and the already established noncontrast head CT criteria; 4 there was a higher percentage of vascular origin among patients with higher scores. Further investigation on which combination of parameters produces the highest and lowest risk would help determine which patients should undergo CTA as part of the diagnostic workup. More importantly, such an analysis may provide clarity on which patients can be safely managed without the addition of CTA. Furthermore, the quantitative contribution of each parameter to the probability of a positive CT angiogram has not been investigated.
In the current study, we attempted to identify groups of patients that would not benefit from CTA as part of the diagnostic workup and to individually quantify risk factors that could increase the yield of CTA in the detection of vascular sources in patients with nontraumatic nonsubarachnoid ICH. In agreement with the current literature, we identified a vascular origin in 13.2% of the patients with spontaneous ICH who underwent CTA. Multivariate regression analysis identified factors that were significantly associated with positive CTA. Specifically, patients younger than 65 years old, female patients, nonsmokers, patients with intraventricular hemorrhage, and patients without hypertension were respectively 16.36, 14.9, 103.8, 9.42, and 515.78 times more likely to have a positive CT angiogram than the patients without these risk factors. It appears, therefore, that preexisting hypertension is the most significant factor for developing ICH in patients without a structural vascular cause. Interestingly, smoking also appears to have a major effect on spontaneous ICH.
Further subgroup analysis demonstrated that patients older than 65 years of age, who had preexisting hypertension, and location of hemorrhage in the basal ganglia or cerebellum were never found to have a positive CT angiogram (68 patients). Patients with these demographics may be managed safely without obtaining CTA in the workup. Because these older patients are more likely to have worse renal function, eliminating CTA for screening in these patients may significantly reduce renal complications. In addition, all patients younger than 45 years of age without hypertension, smoking history, and impaired coagulation had a structural cause of hemorrhage found on further workup (34 patients). Most were identified on CTA, but 1 patient was found to have an AVM on subsequent DSA, and 2 patients had cavernous malformations discovered on MRI. All of these patients eventually required DSA for diagnosis or treatment planning; thus CTA may be safely eliminated from the diagnostic workup of patients with these characteristics as well.
For patients who present with spontaneous ICH (without SAH, history of trauma, or malignancy) in the emergency room and belong in the first group (older than 65 years of age, with preexisting hypertension, and location of hemorrhage in the basal ganglia or cerebellum), the clinician should have an extremely high threshold to perform CTA. Young patients who belong in the second group (younger than 45 years of age without hypertension, smoking history, and impaired coagulation) should all undergo an angiographic study for further investigation. Given that all those patients in our study eventually underwent a conventional angiogram for further lesion characterization or treatment (and in 1 case for definitive diagnosis given the negative CTA), the use of DSA could be considered as a first-line screening tool for this subgroup of patients, to avoid the additional radiation and contrast exposure. If DSA is negative, MRI should be performed to investigate the possibility of a cavernous malformation or newly diagnosed tumor. In the rest of the patients (155 patients in the current series) no definitive conclusion can be drawn about the necessity of an initial angiographic study, and therefore the decision needs to be tailored based on the clinical scenario and the presence of the aforementioned risk factors.
The present study has several limitations. The results are affected by its retrospective nature, because we included patients who presented with ICH and underwent CTA. The results are affected by a selection bias, because patients who were believed clinically to have a low possibility of ICH did not undergo CTA. In addition, the patients who underwent further testing after negative CTA were selected based on the clinician's judgment, and therefore the true sensitivity of CTA cannot be derived.
Conclusions
For patients with acute ICH, several criteria should factor into the decision of whether to perform CTA. The most significant of these factors is hypertension. Patients older than 65, with hypertension, and location of hemorrhage in the basal ganglia or cerebellum have an extremely low likelihood of a vascular lesion and can be safely managed without CTA. Patients younger than 45 years, without risk factors of smoking or anticoagulation, have a very high likelihood of a structural vascular lesion. These patients may best be managed using DSA as the first diagnostic study, because DSA will eventually be required for most of these patients. Patients who do not fit into these groups can safely and effectively be screened with CTA as part of the diagnostic workup.
